Annual Accounts Payable
$8.88 M
-$1.47 M-14.23%
31 December 2023
Summary:
Aclaris Therapeutics annual accounts payable is currently $8.88 million, with the most recent change of -$1.47 million (-14.23%) on 31 December 2023. During the last 3 years, it has risen by +$3.62 million (+68.98%). ACRS annual accounts payable is now -23.96% below its all-time high of $11.68 million, reached on 31 December 2018.ACRS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$7.66 M
+$393.00 K+5.41%
30 September 2024
Summary:
Aclaris Therapeutics quarterly accounts payable is currently $7.66 million, with the most recent change of +$393.00 thousand (+5.41%) on 30 September 2024. Over the past year, it has dropped by -$1.99 million (-20.58%). ACRS quarterly accounts payable is now -56.91% below its all-time high of $17.78 million, reached on 30 September 2019.ACRS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.2% | -20.6% |
| 3 y3 years | +69.0% | +1.3% |
| 5 y5 years | -24.0% | -56.9% |
ACRS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.2% | +69.0% | -32.9% | +34.4% |
| 5 y | 5 years | -24.0% | +69.0% | -56.9% | +80.5% |
| alltime | all time | -24.0% | +2415.0% | -56.9% | +845.9% |
Aclaris Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.66 M(+5.4%) |
| June 2024 | - | $7.27 M(-32.8%) |
| Mar 2024 | - | $10.81 M(+21.8%) |
| Dec 2023 | $8.88 M(-14.2%) | $8.88 M(-8.0%) |
| Sept 2023 | - | $9.65 M(-15.6%) |
| June 2023 | - | $11.43 M(+39.5%) |
| Mar 2023 | - | $8.19 M(-20.9%) |
| Dec 2022 | $10.35 M(+3.7%) | $10.35 M(+35.0%) |
| Sept 2022 | - | $7.67 M(+34.4%) |
| June 2022 | - | $5.70 M(-29.8%) |
| Mar 2022 | - | $8.12 M(-18.7%) |
| Dec 2021 | $9.98 M(+90.0%) | $9.98 M(+32.0%) |
| Sept 2021 | - | $7.56 M(+78.2%) |
| June 2021 | - | $4.24 M(-41.8%) |
| Mar 2021 | - | $7.29 M(+38.8%) |
| Dec 2020 | $5.25 M(-47.0%) | $5.25 M(+3.4%) |
| Sept 2020 | - | $5.08 M(-7.7%) |
| June 2020 | - | $5.50 M(-20.8%) |
| Mar 2020 | - | $6.95 M(-30.0%) |
| Dec 2019 | $9.92 M | $9.92 M(-44.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $17.78 M(+25.6%) |
| June 2019 | - | $14.16 M(-2.8%) |
| Mar 2019 | - | $14.57 M(+24.8%) |
| Dec 2018 | $11.68 M(+49.3%) | $11.68 M(-15.0%) |
| Sept 2018 | - | $13.73 M(+9.8%) |
| June 2018 | - | $12.50 M(+53.3%) |
| Mar 2018 | - | $8.15 M(+4.3%) |
| Dec 2017 | $7.82 M(+174.9%) | $7.82 M(+20.7%) |
| Sept 2017 | - | $6.48 M(+10.9%) |
| June 2017 | - | $5.85 M(+62.3%) |
| Mar 2017 | - | $3.60 M(+26.7%) |
| Dec 2016 | $2.85 M(+251.2%) | $2.85 M(+60.4%) |
| Sept 2016 | - | $1.77 M(-46.4%) |
| June 2016 | - | $3.31 M(+17.8%) |
| Mar 2016 | - | $2.81 M(+246.7%) |
| Dec 2015 | $810.00 K(-35.9%) | $810.00 K(-15.4%) |
| Sept 2015 | - | $958.00 K(+0.1%) |
| June 2015 | - | $957.00 K(-24.2%) |
| Dec 2014 | $1.26 M(+257.8%) | $1.26 M |
| Dec 2013 | $353.00 K | - |
FAQ
- What is Aclaris Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual accounts payable year-on-year change?
- What is Aclaris Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly accounts payable year-on-year change?
What is Aclaris Therapeutics annual accounts payable?
The current annual accounts payable of ACRS is $8.88 M
What is the all time high annual accounts payable for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual accounts payable is $11.68 M
What is Aclaris Therapeutics annual accounts payable year-on-year change?
Over the past year, ACRS annual accounts payable has changed by -$1.47 M (-14.23%)
What is Aclaris Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ACRS is $7.66 M
What is the all time high quarterly accounts payable for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly accounts payable is $17.78 M
What is Aclaris Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ACRS quarterly accounts payable has changed by -$1.99 M (-20.58%)